+987.9%
MRNA vs GD
+9.0%
+978.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GD | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -2.6% | +15.7% | +13.9% |
| 7D | +20.6% | +3.0% | +17.7% | +19.0% |
| 30D | +27.1% | +10.5% | +16.6% | +21.1% |
| 3M | +353.4% | -5.0% | +358.3% | +366.9% |
| 6M | +446.3% | +5.5% | +440.8% | +420.8% |
| YTD | +776.2% | +10.3% | +765.8% | +693.3% |
| 1Y | +987.9% | +8.2% | +979.8% | +931.6% |
| All | +987.9% | +9.0% | +978.9% | +931.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GD.
Daily Out/Under-Performance
Portfolio return minus GD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling